# Colorado MED Rules 2025 - Part 12 of 17

siness or business entity 
and geographical location. To the extent authorized by Rule 3-215 – Regulated Marijuana 
Businesses: Shared Licensed Premises and Operational Separation, a Medical Marijuana 
Transporter may share a location with an identically owned Retail Marijuana Transporter. 
However, a separate license is required for each specific business or business entity, regardless 
of geographical location. 
B. Transportation of Medical Marijuana and Medical Marijuana Product Authorized. A Medical 
Marijuana Transporter may take transportation orders, receive, transport, temporarily store, and 
deliver Medical Marijuana to a Medical Marijuana Business, a Retail Marijuana Cultivation Facility 
or Accelerator Cultivator in accordance with Rules 5-235 and, 6-230, and 6-730, or to a Pesticide 
Manufacturer. A Medical Marijuana Transporter may not sell, give away, buy, or receive 
complimentary Medical Marijuana under any circumstances. A Medical Marijuana Transporter 
does not include a Licensee that transports its own Medical Marijuana. 
C. Authorized Sources of Medical Marijuana. A Medical Marijuana Transporter may only transport 
and store Medical Marijuana that it receives directly from a Medical Marijuana Business in 
accordance with the 3-600 Series Rules. 
D. Authorized On-Premises Storage. A Medical Marijuana Transporter is authorized to store 
transported Medical Marijuana on its Licensed Premises or permitted off-premises storage facility. 
All transported Medical Marijuana must be secured in a Limited Access Area, and tracked 
consistently with the inventory tracking rules. 
E. Delivery to Patients Pursuant to Delivery Permit. 
1. Repealed.Prior to January 2, 2021, all Medical Marijuana Transporters are prohibited 
from delivering Regulated Marijuana to patients. 
2. After January 2, 2021, oOnly Medical Marijuana Transporters that possess a valid 
delivery permit may deliver Medical Marijuana pursuant to contracts with Medical 
Marijuana Stores that also possess valid delivery permits. All deliveries of Medical 
Marijuana to patients must comply with all requirements of Rule 3-615. 
3. Repealed. 
Basis and Purpose – 5-510 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(n), 44-10-203(3)(c), 44-10-401(2)(a)(V), 44-10-505, 
C.R.S. The purpose of this rule is to clarify those acts that are limited in some fashion or prohibited by a 
Medical Marijuana Transporter. This Rule 5-510 was previously Rule M 1602, 1 CCR 212-1. 
5-510 – Medical Marijuana Transporter: General Limitations or Prohibited Acts 
A. Sales, Liens, and Secured Interests Prohibited. A Medical Marijuana Transporter is prohibited 
from buying, selling, or giving away Medical Marijuana or from receiving complimentary Medical 
Marijuana. A Medical Marijuana Transporter shall not place or hold a lien or secured interest on 
Medical Marijuana. 
B. Licensed Premises Permitted. A Medical Marijuana Transporter shall maintain a Licensed 
Premises if it: (1) temporarily stores any Medical Marijuana, or (2) modifies any information in the 
Inventory Tracking System generated transport manifest. The Licensed Premises shall be in a 
local jurisdiction that authorizes the operation of Medical Marijuana Stores. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 371 
1. If a Medical Marijuana Transporter Licensed Premises is shared with a Retail Marijuana 
Transporter Licensed Premises, then the combined Licensed Premises shall be in a local 
jurisdiction that authorizes the operation of both Medical Marijuana Stores and Retail 
Marijuana Stores. 
2. A Medical Marijuana Transporter may add or remove a Licensed Premises, other than an 
Off-Premises Storage Facility, pursuant to Rule 2-255, Change of Location of a 
Regulated Marijuana Business. 
C. Off-Premises Storage Permit. A Medical Marijuana Transporter may maintain one or more 
permitted off-premises storage facilities. See Rule 3-610 – Off-Premises Storage of Regulated 
Marijuana and Regulated Marijuana Product: All Regulated Marijuana Businesses. 
D. Storage Duration. A Medical Marijuana Transporter shall not store Medical Marijuana for longer 
than seven days from receiving it at its Licensed Premises or off-premises storage facility. The 
total allowable seven day storage duration begins and applies regardless of which of the Medical 
Marijuana Transporter’s premises receives the Medical Marijuana first, (i.e. the Medical Marijuana 
Transporter’s Licensed Premises, or any of its off-premises storage facilities). A Medical 
Marijuana Transporter with a valid delivery permit may store Medical Marijuana for delivery to 
patients pursuant to the delivery permit for no longer than seven days from receipt at its Licensed 
Premises or off-premises storage facility. 
E. Control of Medical Marijuana. A Medical Marijuana Transporter is responsible for the Medical 
Marijuana once it takes control of the Medical Marijuana and until the Medical Marijuana 
Transporter delivers it to another Medical Marijuana Business, Retail Marijuana Cultivation 
Facility or Accelerator Cultivator in accordance with Rules 5-235 and, 6-230, and 6-730, Pesticide 
Manufacturer, or deliveries to a patient, parent, or guardian pursuant to a valid delivery permit. 
For purposes of this Rule, taking control of the Medical Marijuana means removing it from the 
Medical Marijuana Business’s Licensed Premises and placing the Medical Marijuana in the 
transport vehicle or the Delivery Motor Vehicle. 
F. Location of Orders Taken and Delivered. A Medical Marijuana Transporter is permitted to take 
orders on the Licensed Premises of any Medical Marijuana Business to transport Medical 
Marijuana between Medical Marijuana Businesses. The Medical Marijuana Transporter shall 
deliver the Medical Marijuana to the Licensed Premises of a licensed Medical Marijuana 
Business, or Pesticide Manufacturer. A Medical Marijuana Transporter may also deliver Medical 
Marijuana to patients, parents, or guardians pursuant to a contract with a Medical Marijuana Store 
if it possesses a valid delivery permit. 
G. A Medical Marijuana Transporter shall receive Medical Marijuana from the originating Licensee 
packaged in the way that it is intended to be delivered to the final destination Licensee, or 
Pesticide Manufacturer. The Medical Marijuana Transporter shall deliver the Medical Marijuana in 
the same, unaltered packaging to the final destination Licensee. 
H. A Medical Marijuana Transporter with a valid delivery permit shall receive Medical Marijuana that 
has been weighed, packaged, prepared, and labeled for delivery on the Licensed Premises of a 
Medical Marijuana Store or at the Medical Marijuana Store’s off-premises storage facility after 
receipt of a delivery order. Medical Marijuana cannot be placed into a Delivery Motor Vehicle until 
after an order has been received and the Medical Marijuana has been packaged and labeled for 
delivery to the patient, parent, or guardian as required by the 3-1000 Series Rules. 
I. A Medical Marijuana Transporter must not deliver Medical Marijuana to patients, parents, or 
guardians while also transporting Regulated Marijuana between Licensed Premises in the 
Delivery Motor Vehicle. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 372 
J. Opening of Sealed Packages or Containers and Re-Packaging Prohibited. A Medical Marijuana 
Transporter shall not open Containers of Medical Marijuana. Medical Marijuana Transporters are 
prohibited from re-packaging Medical Marijuana. 
K. Temperature-Controlled Transport Vehicles. A Medical Marijuana Transporter shall utilize 
temperature-controlled transport vehicles when necessary to prevent spoilage of the transported 
Medical Marijuana. 
L. Damaged, Refused, or Undeliverable Medical Marijuana. Any damaged Medical Marijuana that is 
undeliverable to the final destination Medical Marijuana Business, or any Medical Marijuana that 
is refused by the final destination Medical Marijuana Business shall be transported back to the 
originating Medical Marijuana Business. Any Medical Marijuana that cannot be delivered to the 
patient, parent, or guardian pursuant to a valid delivery permit shall be returned to the originating 
Medical Marijuana Store or the Medical Marijuana Store’s off-premises storage facility within the 
same business day or pursuant to paragraph (D) of this Rule. 
M. Transport of Medical Marijuana Vegetative Plants Authorized. Medical Marijuana Vegetative 
plants may only be transported between Licensed Premises and such transport shall only be 
permitted due to an approved change of location pursuant to Rule 2-255 or due to a one-time 
Transfer pursuant to Rule 3-805. Transportation of Vegetative plants to a permitted off-premises 
storage facility shall not be allowed. This restriction shall not apply to Immature Plants. 
N. Only persons licensed by the State Licensing Authority may occupy a transport vehicle while 
transporting Regulated Marijuana. 
5-600 Series – Medical Marijuana Business Operators 
Basis and Purpose – 5-605 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. The purpose of this rule is 
to establish the license privileges of a Medical Marijuana Business Operator license. This Rule 5-605 was 
previously Rule M 1701, 1 CCR 212-1. 
5-605 – Medical Marijuana Business Operator: License Privileges 
A.  Privileges Granted. A Medical Marijuana Business Operator shall only exercise those privileges 
granted to it by the Marijuana Code, the rules promulgated pursuant thereto and the State 
Licensing Authority. A Medical Marijuana Business Operator may exercise those privileges only 
on behalf of the Medical Marijuana Business(es) it operates. A Medical Marijuana Business shall 
not contract to have more than one Medical Marijuana Business Operator providing services to 
the Medical Marijuana Business at any given time. A Medical Marijuana Business Operator may 
not provide any operational services to a Marijuana Research and Development Facility. 
B. Licensed Premises of the Medical Marijuana Business(es) Operated. A separate license is 
required for each specific Medical Marijuana Business Operator, and each licensed or registered 
Medical Marijuana Business Operator may operate one or more other Medical Marijuana 
Business(es). A Medical Marijuana Business Operator shall not have its own Licensed Premises, 
but shall maintain its own place of business, and may exercise the privileges of a Medical 
Marijuana Business Operator at the Licensed Premises of the Medical Marijuana Business(es) it 
operates. 
C. Entities Eligible to Hold Medical Marijuana Business Operator License or Registration. A Medical 
Marijuana Business Operator license may be held only by a business entity, including, but not 
limited to, a corporation, limited liability company, partnership, or sole proprietorship. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 373 
D. Separate Place of Business. A Medical Marijuana Business Operator shall designate and 
maintain a place of business separate from the Licensed Premises of any Medical Marijuana 
Business(es) it operates. A Medical Marijuana Business Operator’s separate place of business 
shall not be considered a Licensed Premises, and shall not be subject to the requirements 
applicable to the Licensed Premises of other Medical Marijuana Businesses, except as set forth 
in Rules 5-610 and 5-620. Possession, storage, use, cultivation, manufacture, sale, distribution, 
or testing of Medical Marijuana or Medical Marijuana Product is prohibited at a Medical Marijuana 
Business Operator’s separate place of business. 
E. Agency Relationship and Discipline for Violations. A Medical Marijuana Business Operator and 
each of its Controlling Beneficial Owners required to hold an Owner License, as well as the 
agents and employees of the Medical Marijuana Business Operator, shall be agents of the 
Medical Marijuana Business(es) the Medical Marijuana Business Operator is contracted to 
operate, when engaged in activities related, directly or indirectly, to the operation of such Medical 
Marijuana Business(es), including for purposes of taking administrative action against the Medical 
Marijuana Business being operated. See § 44-10-901(1), C.R.S. Similarly, a Medical Marijuana 
Business Operator and its Controlling Beneficial Owners required to hold an Owner License, as 
well as the officers, agents and employees of the Medical Marijuana Business Operator, may be 
disciplined for violations committed by the Controlling Beneficial Owners, agents or employees of 
the Medical Marijuana Business acting under their direction or control. A Medical Marijuana 
Business Operator may also be disciplined for violations not directly related to a Medical 
Marijuana Business it is operating. 
F. Compliance with Applicable State and Local Law, Ordinances, Rules, and Regulations. A Medical 
Marijuana Business Operator, and each of its Controlling Beneficial Owners, agents and 
employees engaged, directly or indirectly, in the operation of the Medical Marijuana Business(es) 
it operates, shall comply with all state and local laws, ordinances, rules, and regulations 
applicable to the Medical Marijuana Business(es) being operated. 
Basis and Purpose – 5-610 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. The purpose of this rule is 
to clarify those acts that are limited in some fashion, or prohibited, by a Medical Marijuana Business 
Operator. This Rule 5-610 was previously Rule M 1702, 1 CCR 212-1. 
5-610 – Medical Marijuana Business Operators: General Limitations or Prohibited Acts 
A. Financial Interest. A Person who holds an Owner’s Interest in a Medical Marijuana Business 
Operator may also hold an Owner’s Interest in another Medical Marijuana Business. A Medical 
Marijuana Business may be operated by a Medical Marijuana Business Operator where each has 
one or more Controlling Beneficial Owners or Passive Beneficial Owners in common. A Person 
may receive compensation for services provided by a Medical Marijuana Business Operator in 
accordance with these rules. 
B. Sale of Marijuana Prohibited. A Medical Marijuana Business Operator is prohibited from selling, 
distributing, or Transferring Medical Marijuana to another Medical Marijuana Business, a patient, 
or a consumer, except when acting as an agent of a Medical Marijuana Business(es) operated by 
the Medical Marijuana Business Operator. 
C. Consumption Prohibited. A Medical Marijuana Business Operator, and its Controlling Beneficial 
Owners, Passive Beneficial Owners, agents and employees, shall not permit the consumption of 
marijuana or marijuana products at its separate place of business. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 374 
D. Inventory Tracking System. A Medical Marijuana Business Operator, and any of its Controlling 
Beneficial Owners, agents, or employees engaged in the operation of the Medical Marijuana 
Business(es) it operates, must use the Inventory Tracking System account of the Medical 
Marijuana Business(es) it operates, in accordance with all requirements, limitations, and 
prohibitions applicable to the Medical Marijuana Business(es) it operates. 
E. Compliance with Requirements and Limitations Applicable to the Medical Marijuana Business(es) 
Operated. In operating any other Medical Marijuana Business(es), a Medical Marijuana Business 
Operator, and its Controlling Beneficial Owners, agents and employees, shall comply with all 
requirements, limitations and prohibitions applicable to the type(s) of Medical Marijuana 
Business(es) being operated, under state and local laws, ordinances, rules, and regulations, and 
may be disciplined for violation of the same. 
F. Inventory Tracking System Access. A Medical Marijuana Business may grant access to its 
Inventory Tracking System account to the Controlling Beneficial Owners who are required to hold 
Owner Licenses, as well as the licensed agents and employees of a Medical Marijuana Business 
Operator having duties related to Inventory Tracking System activities of the Medical Marijuana 
Business(s) being operated. 
1. The Controlling Beneficial Owners, agents, and employees of a Medical Marijuana 
Business Operator granted access to a Medical Marijuana Business’s Inventory Tracking 
System account, shall comply with all Inventory Tracking System rules. 
2. At least one Controlling Beneficial Owner or their designee of a Medical Marijuana 
Business being operated by a Medical Marijuana Business Operator must be an 
Inventory Tracking System Trained Administrator for the Medical Marijuana Business’s 
Inventory Tracking System account. That Inventory Tracking System Trained 
Administrator shall control access to its Inventory Tracking System account, and shall 
promptly terminate the access of the Medical Marijuana Business Operator’s Controlling 
Beneficial Owners, agents, and employees: 
a. When its contract with the Medical Marijuana Business Operator expires by its 
terms; 
b. When its contract with the Medical Marijuana Business Operator is terminated by 
any party; or 
c. When it is notified that the license of the Medical Marijuana Business Operator, 
or a specific Controlling Beneficial Owner, agent or employee of the Medical 
Marijuana Business Operator, has expired, or has been suspended or revoked. 
G. Limitations on Use of Documents and Information Obtained from Medical Marijuana Businesses. 
A Medical Marijuana Business Operator, and its agents and employees, shall maintain the 
confidentiality of documents and information obtained from the other Medical Marijuana 
Business(es) it operates, and shall not use or disseminate documents or information obtained 
from a Medical Marijuana Business it operates for any purpose not authorized by the Marijuana 
Code and the rules promulgated pursuant thereto, and shall not engage in data mining or other 
use of the information obtained from a Medical Marijuana Business to promote the interests of the 
Medical Marijuana Business Operator or its Controlling Beneficial Owners, Passive Beneficial 
Owners, Indirect Financial Interest Holders, agents or employees, or any Person other than the 
Medical Marijuana Business it operates. 
H. Form and Structure of Allowable Agreement(s) Between Operators and Owners. Any agreement 
between a Medical Marijuana Business and a Medical Marijuana Business Operator: 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 375 
1. Must acknowledge that the Medical Marijuana Business Operator, and its Controlling 
Beneficial Owners, agents and employees who are engaged, directly or indirectly, in 
operating the Medical Marijuana Business, are agents of the Medical Marijuana Business 
being operated, and must not disclaim an agency relationship; 
2. May provide for the Medical Marijuana Business Operator to receive direct remuneration 
from the Medical Marijuana Business, including a portion of the profits of the Medical 
Marijuana Business being operated, subject to the following limitations: 
a. The portion of the profits to be paid to the Medical Marijuana Business Operator 
shall be commercially reasonable, and in any event shall not exceed the portion 
of the net profits to be retained by the Medical Marijuana Business being 
operated; 
b. The Medical Marijuana Business Operator shall not be granted, and may not 
accept: 
i. A security interest in the Medical Marijuana Business being operated, or 
in any assets of the Medical Marijuana Business; 
ii. An ownership or membership interest, shares, or shares of stock, or any 
right to obtain any direct or indirect beneficial ownership interest in the 
Medical Marijuana Business being operated, or a future or contingent 
right to the same, including but not limited to options or warrants; 
c. The Medical Marijuana Business Operator shall not guarantee the Medical 
Marijuana Business’s debts or production levels. 
3. Shall permit the Medical Marijuana Business being operated to terminate the contract 
with the Medical Marijuana Business Operator at any time, with or without cause. 
I. A Medical Marijuana Business Operator may engage in dual operation of a Medical Marijuana 
Business and a Retail Marijuana Business at a single location, to the extent the Medical 
Marijuana Business being operated is permitted to do so pursuant to subsection 44-10-501(2)(a), 
C.R.S., and the Medical Marijuana Business Operator shall comply with the rules promulgated 
pursuant to the Marijuana Code, including the requirement of obtaining a valid license as a Retail 
Marijuana Business Operator. 
J. Any Medical Marijuana Business Operators and the Medical Marijuana Business Operator’s 
Owner Licensee(s) that are appointed by a court to serve as a receiver, personal representative, 
executor, administrator, guardian, conservator, trustee, or similarly situated Person and take 
possession of, operate, manage, or control a Medical Marijuana Business must comply with Rule 
2-275(F). 
Basis and Purpose – 5-615 
The statutory authority for this rule includes but is not limited to sections, 44-10-202(1)(c), 44-10-
203(1)(c), 44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. The purpose of 
this rule is to establish license requirements for the Medical Marijuana Business Operator’s Controlling 
Beneficial Owners, agents and employees, including those directly or indirectly engaged in the operation 
of other Medical Marijuana Business(es). This Rule 5-615 was previously Rule M 1703, 1 CCR 212-1. 
5-615 – Medical Marijuana Business Operators: Employee Licenses for Personnel 
A. Required Licenses. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 376 
1. Owner Licenses. All natural persons who are Controlling Beneficial Owners in a Medical 
Marijuana Business Operator must have a valid Owner License, associated with the 
Medical Marijuana Business Operator license. Such an Owner License shall satisfy all 
licensing requirements for work related to the business of the Medical Marijuana 
Business Operator and for work performed on behalf of, or at the Licensed Premises of, 
the Medical Marijuana Business(es) operated by the Medical Marijuana Business 
Operator. 
2. Employee Licenses. All natural persons who are agents or employees of a Medical 
Marijuana Business Operator that are actively engaged, directly or indirectly, in the 
management, supervision, or operation of one or more other Medical Marijuana 
Businesses, including but not limited to all agents or employees who will come into 
contact with Medical Marijuana, who will have access to Limited Access Areas, or who 
will have access to the Inventory Tracking System account of the Medical Marijuana 
Business(es) being operated, must hold a valid Employee License. The Employee 
License shall satisfy all licensing requirements for work related to the business of the 
Medical Marijuana Business Operator and for work at the Licensed Premises of, or on 
behalf of, the Medical Marijuana Business(es) operated by the Medical Marijuana 
Business Operator. 
B. Employee Licenses Not Required. Employee Licenses are not required for Passive Beneficial 
Owners of a Medical Marijuana Business Operator or for natural persons who will not come into 
contact with Medical Marijuana, will not have access to Limited Access Area(s) of the Medical 
Marijuana Business(es) being operated, and will not have access to the Inventory Tracking 
System account of the Medical Marijuana Business(es) being operated. 
C. Designation of Management Personnel of a Medical Marijuana Business Operated by a Medical 
Marijuana Business Operator. If a Medical Marijuana Business Operator is contracted to manage 
the overall operations of a Medical Marijuana Business’s Licensed Premises, the Medical 
Marijuana Business shall designate separate and distinct management personnel on the 
Licensed Premises who is an officer, agent, or employee of the Medical Marijuana Business 
Operator, which shall be a natural person with a valid Owner License or Employee License, as 
set forth in paragraph (A) of this Rule, and the Medical Marijuana Business shall comply with the 
reporting provisions of subsection 44-10-313, C.R.S. 
Basis and Purpose – 5-620 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(2)(o), 44-10-401(2)(a)(VI), and 44-10-506, C.R.S. The purpose of this rule is 
to establish records retention standards for a Medical Marijuana Business Operators. This Rule 5-620 
was previously Rule M 1704, 1 CCR 212-1. 
5-620 – Medical Marijuana Business Operators: Business Records Required 
A. General Requirement. A Medical Marijuana Business Operator must maintain all required 
business records as set forth in Rule 3-905 - Business Records Required, except that: 
1. A Medical Marijuana Business Operator is not required to maintain secure facility 
information, diagrams of its designated place of business, or a visitor log for its separate 
place of business, because a Medical Marijuana Business Operator will not come into 
contact with Medical Marijuana at its separate place of business; and 
2. A Medical Marijuana Business Operator is not required to maintain records related to 
inventory tracking, or transport, because a Medical Marijuana Business Operator is 
prohibited from engaging in activities on its own behalf that would require inventory 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 377 
tracking or transport. All records relating to inventory tracking activities and records 
related to transport pertaining to the Medical Marijuana Business(es) operated by the 
Medical Marijuana Business Operator shall be maintained at the Licensed Premises of 
such Medical Marijuana Business(es). 
B. All records required to be maintained shall be maintained at the Licensed Premises of the 
Medical Marijuana Business(es) it operates. 
5-700 Series – Marijuana Research and Development Facilities 
Basis and Purpose – 5-705 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(j), 44-10-203(1)(k), 44-10-203(2)(s), 44-10-401(1)(a)(VII), and 44-10-507, C.R.S. The 
purpose of this rule is to establish and clarify the distinct license privilege granted to Marijuana Research 
and Development Facilities by the State Licensing Authority. This Rule 5-705 was previously Rule M 
1901, 1 CCR 212-1. 
5-705 – Marijuana Research and Development Facilities: License Privileges 
A. License Privileges. 
1. Licensed Premises. A Marijuana Research and Development Facility may share a 
Licensed Premises with a commonly owned Medical Marijuana Testing Facility. 
Additionally, a Marijuana Research and Development Facility with an R&D Co-Location 
Permit may share a Licensed Premises with a commonly owned Medical Marijuana 
Products Manufacturer, Retail Marijuana Products Manufacturer, Medical Marijuana 
Cultivation Facility, or Retail Marijuana Cultivation Facility. 
a. If a Marijuana Research and Development Facility shares its Licensed Premises 
with a commonly owned Medical Marijuana Testing Facility, the Licensees shall 
physically segregate all Medical Marijuana used for research purposes in order to 
prevent contamination or any other effect on Medical Marijuana submitted to the 
Medical Marijuana Testing Facility for testing. 
b. If a Marijuana Research and Development Facility shares its Licensed Premises 
with a commonly owned Medical Marijuana Products Manufacturer, Retail 
Marijuana Products Manufacturer, Medical Marijuana Cultivation Facility, or 
Retail Marijuana Cultivation Facility, the Marijuana Research and Development 
Facility must first obtain an R&D Co Location Permit for that Licensed Premises 
and must comply with all terms and conditions of the R&D Co-Location Permit. 
2. Authorized Sources of Medical Marijuana. A Medical Marijuana Cultivation Facility and 
Medical Marijuana Products Manufacturer may Transfer Medical Marijuana to a 
Marijuana Research and Development Facility. 
a. A Marijuana Research and Development Facility may also accept and possess 
Regulated Marijuana obtained in accordance with an approved Research Project. 
b. Upon receipt of Regulated Marijuana pursuant to Rule 5-705(A)(2)(a), a 
Marijuana Research and Development Facility shall immediately enter the 
Regulated Marijuana as Medical Marijuana in its Inventory Tracking System and 
shall follow all requirements of the Marijuana Code and these Rules including but 
not limited to inventory tracking and packaging and labeling. As part of and in 
compliance with the conditions of an approved Research Project, a Marijuana 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 378 
Research and Development Facility may Transfer the Medical Marijuana to 
another Marijuana Research and Development Facility or to a Medical or Retail 
Marijuana Testing Facility. In no event shall any marijuana obtained or 
Transferred pursuant to this Rule be consumed by humans or utilized in human 
subject research. 
3. Cultivation of Marijuana Authorized. A Marijuana Research and Development Facility 
may grow, cultivate, possess, and Transfer Medical Marijuana for use in research only. 
4. Production of Marijuana Concentrate. A Marijuana Research and Development Facility 
and a Medical Marijuana Cultivation Facility are subject to the same restrictions 
concerning Medical Marijuana Concentrate production. Therefore, a Marijuana Research 
and Development Facility may produce Medical Marijuana Concentrate only as allowed 
by, and in conformance with, Rule 5-220(A)-(B). 
5. Production of Marijuana Products. A Marijuana Research and Development Facility and a 
Medical Marijuana Products Manufacturer are subject to the same restrictions concerning 
Medical Marijuana Product manufacturing. Therefore, a Marijuana Research and 
Development Facility may manufacture Medical Marijuana Product only as allowed by, 
and in conformance with, Rule 5-305. 
5.5. Production of Semi-Synthetic Cannabinoids. A Marijuana Research and Development 
Facility may manufacture Semi-synthetic Cannabinoids derived from Medical Marijuana. 
6. Authorized Marijuana Transport. A Marijuana Research and Development Facility is 
authorized to utilize a licensed Medical Marijuana Transporter for transportation of 
Medical Marijuana to other Marijuana Research and Development Facility Licensees so 
long as the place where transportation orders are taken and delivered is a Marijuana 
Research and Development Facility. Nothing in this Rule prevents a Marijuana Research 
and Development Facility from transporting its own Medical Marijuana to other Marijuana 
Research and Development Facilities. 
B. R&D Co-Location Permit. A Marijuana Research and Development Facility may obtain an R&D 
Co-Location Permit to operate at the same Licensed Premises as a commonly owned Medical 
Marijuana Products Manufacturer, Retail Marijuana Products Manufacturer, Medical Marijuana 
Cultivation Facility, or Retail Marijuana Cultivation Facility under the following circumstances: 
1. The Marijuana Research and Development Facility must apply on current Division forms 
and pay any applicable fees. 
2. A Marijuana Research and Development Facility may only apply for and hold an R&D Co-
Location Permit if the Local Licensing Authority or Local Jurisdiction allow for Marijuana 
Research and Development Facility to operate at the same location as the specified 
Regulated Marijuana Business. Any R&D Co-Location Permit issued by the Division is 
conditioned upon the Marijuana Research and Development Facility’s receipt of all 
required Local Licensing Authority or Local Jurisdiction approvals or acknowledgements. 
3. The Marijuana Research and Development Facility and the specified Regulated 
Marijuana Business shall be commonly owned. 
4. Prior to operating in the same Licensed Premises pursuant to an R&D Co-Location 
Permit, the Marijuana Research and Development Facility shall submit a co-location plan 
and Standard Operating Procedures to the Division. The co-location plan and Standard 
Operating Procedures shall demonstrate protocols to prevent cross-contamination and 
protect public health and safety, including but not limited to: 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 379 
a. Standards and controls for maintaining physical separation between the 
Marijuana Research and Development Facility’s research activities and the 
cultivating or manufacturing activities of the co-located Regulated Marijuana 
Business; and 
b. Standards and controls for maintaining physical separation between the 
Marijuana Research and Development Facility’s Medical Marijuana and the co-
located Regulated Marijuana Business’s Regulated Marijuana. 
5. The Division may request the assistance of the Colorado Department of Public Health 
and Environment or any other state or local agency in reviewing the co-location plan and 
Standard Operating Procedures, and in determining whether the co-location plan and 
Standard Operating Procedures demonstrate protocols to prevent cross-contamination 
and protect public health and safety. 
6. Modifying the co-location plan and Standard Operating Procedures shall be considered a 
significant change to the Licensed Premises. See Rule 2-260 – Changing, Altering, or 
Modifying the Licensed Premises. 
7. Record keeping, inventory tracking, packaging and labeling for the Marijuana Research 
and Development Facility and co-located Regulated Marijuana Business must enable the 
Division, Local Licensing Authority, or Local Jurisdiction to clearly distinguish the 
inventory, transactions, and activities of the Marijuana Research and Development 
Facility from the inventory, transactions, and activities of the co-located Regulated 
Marijuana Business. 
Basis and Purpose - 5-710 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(s), 44-10-313(7), 44-10-401(1)(a)(VII), and 44-10-507, 
C.R.S. The purpose of this rule is to clarify those acts that are prohibited, or limited in some fashion, by a 
Marijuana Research and Development Facility. This Rule 5-710 was previously Rule M 1902, 1 CCR 212-
1. 
5-710 – Marijuana Research and Development Facility: General Limitations or Prohibited Acts 
A. Restrictions Applicable to Any Marijuana Research and Development Facility. 
1. Packaging and Labeling Standards Required. A Marijuana Research and Development 
Facility is prohibited from Transferring to a Licensee or any other Person Medical 
Marijuana that is not packaged and labeled in accordance with these rules. See 3-1000 
Series Rules – Labeling, Packaging, and Product Safety. 
a. Unless the Medical Marijuana was subject to contaminant testing required by the 
Marijuana Code and these rules, a Marijuana Research and Development 
Facility shall disclose to any individual receiving Medical Marijuana as part of an 
approved Research Project that the Medical Marijuana has not been subject to 
mandatory contaminant testing. 
2. Transfers to Individuals. A Marijuana Research and Development Facility is prohibited 
from Transferring Medical Marijuana to any individual, unless as part of an approved 
Research Project. 
3. Consumption Prohibited. A Marijuana Research and Development Facility shall not 
permit the consumption of Medical Marijuana on its Licensed Premises, unless the 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 380 
consumption is part of an approved Research Project and the Marijuana Research and 
Development Facility does not share a Licensed Premises with a Regulated Marijuana 
Business. 
4. Worker Health and Safety. A Marijuana Research and Development Facility shall comply 
with all applicable federal, state, and local laws regarding worker health and safety. 
5. Performance Incentives. A Marijuana Research and Development Facility may not use 
performance-based incentives to compensate its employees, agents, or contractors who 
will conduct research, development, or testing. 
6. Licensure and Research Projects. A Marijuana Research and Development Facility shall 
not engage in any research activities until the State Licensing Authority or its delegate 
approves both (1) its business license application, pursuant to Rule 2-215, and (2) one or 
more Research Project(s), pursuant to Rule 5-715. 
a. A Marijuana Research and Development Facility may submit its business license 
application prior to or in conjunction with its Research Project proposal. Except 
that the Marijuana Research and Development Facility may not engage in any 
research activities except in conjunction with an approved Research Project. 
b. If a Marijuana Research and Development Facility’s license expires or is 
suspended or revoked, the Licensee shall immediately cease all activities 
associated with the privileges of licensure, including but not limited to research. 
B. Restrictions Applicable to Marijuana Research and Development Facilities. 
1. Transfer Restriction. A Marijuana Research and Development Facility may only Transfer 
Medical Marijuana, Medical Marijuana Concentrate, or Medical Marijuana Product to: 
a. A Medical Marijuana Testing Facility for testing; 
b. A natural person as part of and in compliance with the conditions of an approved 
Research Project; 
c. In the case of Medical Marijuana cultivated at the Licensed Premises of the 
Marijuana Research and Development Facility, to another Marijuana Research 
and Development Facility; or 
d. In the case of an Immature Plant that has not been exposed to a chemical 
prohibited by Rule 3-325, to another Medical Marijuana Business. 
Basis and Purpose – 5-715 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(s), 44-10-401(1)(a)(VII), and 44-10-507, C.R.S. The 
purpose of this rule is to ensure that any research or development conducted by a Marijuana Research 
and Development Facility shall be in furtherance of a Research Project approved by the Division. The 
purpose of this rule is also to establish the applicable requirements necessary for Marijuana Research 
and Development Facilities to seek and receive Division approval for all proposed Research Projects. 
This Rule 5-715 was previously Rule M 1904, 1 CCR 212-1. 
5-715 – Marijuana Research and Development Facility: Project Approval 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 381 
A. Project Approval. Prior to engaging in any research activities, a Marijuana Research and 
Development Facility shall obtain approval from the Division for a Research Project by submitting 
a Research Project proposal. Any research or development conducted by a Marijuana Research 
and Development Facility shall be in furtherance of an approved Research Project. 
1. General. A Marijuana Research and Development Facility Applicant or Licensee shall 
seek approval of the Division by submitting its Research Project proposal. 
a. A Research Project proposal shall include a description of the Research Project’s 
defined protocol, clearly articulated goal(s), defined methods and outputs, and a 
defined start and end date. 
i. The description of the proposed Research Project proposal shall include 
the quantity of Medical Marijuana, Medical Marijuana Concentrate, 
and/or Medical Marijuana Product reasonably required to conduct the 
proposed Research Project, the total quantity of which is subject to 
approval by the Division as part an approved Research Project. 
b. A Marijuana Research and Development Facility may enter into contracts or 
agreements with a public higher education research institution or another 
Marijuana Research and Development Facility to conduct the proposed 
Research Project. A Marijuana Research and Development Facility Applicant or 
Licensee shall disclose all contracts or agreements with a public higher 
education research institution or a Marijuana Research and Development 
Facility. 
i. If a Marijuana Research and Development Facility enters into a contract 
or agreement to conduct a Research Project with a public higher 
education research institution, all research activities involving possession 
of Medical Marijuana shall occur at the Marijuana Research and 
Development Facility’s Licensed Premises. Employees, agents, or 
contractors of the public higher education research institution may not 
work at or conduct research activities at the Marijuana Research and 
Development Facility’s Licensed Premises unless they hold an Employee 
License issued by the State Licensing Authority. 
c. A Marijuana Research and Development Facility may submit additional Research 
Project proposals at any time during which its license is current and valid. 
2. Private Research. Unless the proposed Research Project is being conducted in whole or 
in part by a Public Institution or with Public Money, the Marijuana Research and 
Development Facility Applicant or Licensee shall obtain a review of its proposed 
Research Project by one or more independent reviewers. The Division, in its discretion, 
may require a Marijuana Research and Development Facility Applicant or Licensee to 
nominate multiple independent reviewers. The Division must approve each nominated 
independent reviewer. 
a. Fees and Costs. The Applicant or Licensee shall be solely responsible for any 
fees or costs associated with all aspects and all stages of the independent 
reviewer’s services. 
b. Qualifications of an Independent Reviewer. Each independent reviewer 
nominated by a Marijuana Research and Development Facility Applicant or 
Licensee must be a qualified researcher within the field of study that relates to 
proposed Research Project. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 382 
i. The Division may consult with the Colorado Department of Public Health 
and Environment and/or the Colorado Department of Agriculture in 
reviewing whether a nominated independent reviewer is qualified to 
review the Marijuana Research and Development Facility’s Research 
Project. 
ii. The Division, in its discretion, may require a nominated independent 
reviewer or the Marijuana Research and Development Facility to provide 
additional information or analysis that the Division deems pertinent to its 
review of whether to approve the Licensee’s nomination of the 
independent reviewer. 
c. Conflicts of Interest. A Marijuana Research and Development Facility Applicant 
or Licensee must disclose all pre-existing financial, employment, business, or 
personal relationships between the Marijuana Research and Development 
Facility or any of its Owner Licensees and each independent reviewer. In 
determining whether to approve an independent reviewer, the Division may 
consider whether a pre-existing relationship exists that could affect the 
independent reviewer’s independence or appearance of independence. 
d. Independent Reviewer Approval Required. If a Marijuana Research and 
Development Facility Applicant or Licensee nominates an independent reviewer 
who is not approved by the Division, the State Licensing Authority may deny a 
Research Project on that ground unless the Marijuana Research and 
Development Facility Applicant or Licensee nominates another independent 
reviewer who is approved by the Division. 
e. Independent Reviewer Report. After an independent reviewer has been 
approved by the Division, the Marijuana Research and Development Facility 
Applicant or Licensee shall submit a report by the independent reviewer to the 
Division as part of its Research Project proposal. The independent reviewer’s 
report shall address the following criteria as described in the Research Project’s 
description: 
i. The identity of the independent reviewer and his/her employer; 
ii. Any compensation paid by the Marijuana Research and Development 
Facility Applicant or Licensee for the review and report; 
iii. A description of the review conducted by the independent reviewer, 
including but not limited to an identification of all documents that were 
reviewed; 
iv. An analysis by the independent reviewer as to whether the proposed 
Research Project constitutes a type of approved research pursuant to 
Rule 5-720(A) and the reason(s) supporting the reviewer’s analysis; 
v. An assessment of the total quantity of Medical Marijuana reasonably 
required to conduct the proposed Research Project; 
vi. An assessment of whether the proposed Research Project presents any 
type of danger to the public health and/or safety, and/or whether the 
proposed Research Project presents any health or safety risks; 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 383 
vii. An assessment of whether the proposed Research Project has a strong 
scientific basis, appropriate study design, and technically sound scientific 
methodology; 
viii. An assessment of whether the Marijuana Research and Development 
Facility Applicant or Licensee is qualified to perform the proposed 
Research Project, including whether Marijuana Research and 
Development Facility Applicant or Licensee’s employees are qualified to 
perform the proposed Research Project; 
ix. An assessment of whether the Marijuana Research and Development 
Facility Applicant or Licensee has the appropriate resources and 
protocols to conduct the proposed Research Project; 
x. An assessment of whether the Marijuana Research and Development 
Facility Applicant or Licensee has the appropriate personnel, expertise, 
facilities, infrastructure, funding, and other human, animal, or other 
approvals in place to successfully conduct the Research Project, 
including but not limited to the requirements in Rule 5-720(C) and (D); 
xi. The following certification by the independent reviewer: “I hereby certify 
and affirm that I do not have any financial, employment, business, or 
personal relationship with [INSERT MARIJUANA RESEARCH AND 
DEVELOPMENT FACILITY NAME] (“Licensee”) that would influence or 
affect my review of the Licensee’s proposed Research Project activity. 
Other than the fees disclosed herein, neither the Licensee nor any other 
person has given me anything of value or made any promises to me that 
would influence or affect my review of the Licensee’s proposed research 
activity. I further certify and affirm that this report was drafted by me, and 
that the information, analysis, and conclusions herein represent solely 
my work and conclusions.”; and 
xii. The signature of the independent reviewer. 
f. Repealed.The Marijuana Research and Development Facility shall maintain 
copies of all documents and correspondence sent to or from the independent 
reviewer. See Rule 3-905 – Business Records Required. 
g. The Division, in its discretion, may require the independent reviewer and/or the 
Marijuana Research and Development Facility Applicant or Licensee to provide 
additional information or analysis that the Division deems pertinent to its review 
of the Applicant or Licensee’s Research Project proposal. 
h. The State Licensing Authority may decline to approve a Research Project 
proposal if an independent reviewer or the Division through further investigation 
concludes that: 
i. The description of the Research Project does not meet the requirements 
of section 44-10-507, C.R.S., and these rules; 
ii. The proposed Research Project presents a danger to the public health 
and/or safety, and/or the research to be conducted pursuant to the 
Research Project presents any health or safety risks; 
iii. The proposed Research Project lacks scientific value or validity; 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 384 
iv. The Marijuana Research and Development Facility Applicant or Licensee 
is not qualified to perform the proposed research; 
v. The Marijuana Research and Development Facility Applicant or Licensee 
does not have the appropriate resources and/or protocols to conduct the 
proposed research; 
vi. The Marijuana Research and Development Facility Applicant or Licensee 
lacks the appropriate personnel, expertise, facilities, infrastructure, 
funding, or human, animal, or other approvals in place to successfully 
conduct the Research Project, including but not limited to the 
requirements in Rule 5-720(C) and (D); 
vii. The independent reviewer(s) cannot meet the certification requirements 
in this Rule; or 
viii The Marijuana Research and Development Facility Applicant or Licensee 
or the proposed Research Project is otherwise not in compliance with the 
Marijuana Code or these rules. 
3. Projects with Public Institutions or Money. If a Marijuana Research and Development 
Facility Applicant or Licensee's proposed Research Project will be conducted in whole or 
in part with a Public Institution or Public Money, the Division shall refer the Licensee’s 
Research Project proposal to the Scientific Advisory Council established by section 25-
1.5-106.5(3), C.R.S., for review. 
a. The Marijuana Research and Development Facility Applicant or Licensee shall 
supply the Scientific Advisory Council with any information and/or documents 
requested by the Scientific Advisory Council within the deadline imposed by the 
Scientific Advisory Council. A Marijuana Research and Development Facility 
Applicant or Licensee’s failure to supply information and/or documents requested 
by the Scientific Advisory Council within the deadline set by the Scientific 
Advisory Council shall be grounds for denial of the Research Project proposal. 
b. The Scientific Advisory Council shall review the proposed Research Project to 
ensure that the proposed Research Project meets the requirements of Rule 5-
720(A). 
c. The Scientific Advisory Council shall also assess the adequacy of the following: 
i. The proposed Research Project’s quality, study design, value, or impact; 
ii. Whether the Marijuana Research and Development Facility Applicant or 
Licensee has the appropriate personnel, expertise, facilities, 
infrastructure, funding, and human, animal, or other approvals in place to 
successfully conduct the Research Project, including but not limited to 
the requirements in Rule 5-720(C) and (D); and 
iii. Whether the amount of Medical Marijuana the Marijuana Research and 
Development Facility Applicant or Licensee proposes to grow or possess 
is consistent with the proposed Research Project’s scope and goals. 
d. The Scientific Advisory Council shall communicate the results of its review of the 
proposed Research Project to the Division. If the Scientific Advisory Council 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 385 
determines that the requirements of either Psubparagraph (A)(3)(b) or (c) of this 
Rule are not satisfied, then the proposed Research Project shall be denied. 
e. Repealed.The Marijuana Research and Development Facility shall maintain 
copies of all documents and correspondence sent to or from the Scientific 
Advisory Council. See Rule 3-905 – Business Records Required. 
Basis and Purpose – 5-720 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(s), 44-10-401(1)(a)(VII), and 44-10-507, C.R.S. The 
purpose of this rule to establish the limited research purposes authorized for Marijuana Research and 
Development Facilities. The purpose of this rule is also to establish additional requirements for Research 
Projects involving human subjects and animal subjects, as well as restrictions on the use of Pesticides. 
The rule also establishes reporting requirements and explains when the State Licensing Authority may 
require a Marijuana Research and Development Facility to undergo an audit of its research activities. This 
Rule 5-720 was previously Rule M 1905, 1 CCR 212-1. 
5-720 – Marijuana Research and Development Facility: Authorized Research Activities 
A. Authorized Research. A Marijuana Research and Development Facility is authorized to engage in 
the following research at its Licensed Premises: 
1. Chemical Potency and Composition Levels. 
2. Clinical Investigations of Marijuana-Derived Products. 
3. Efficacy and Safety of Administering Marijuana as Part of Medical Treatment. 
4. Genomic Research. 
5. Horticultural Research. 
6. Agricultural Research. 
7. Marijuana-Affiliated Products or Systems. A marijuana-affiliated product or system 
includes products or systems such as marijuana delivery systems and cultivation or 
processing equipment. 
B. Pesticide Research. A Marijuana Research and Development Facility shall not engage in any 
research activities involving Pesticides unless the Marijuana Research and Development Facility 
has applied for and received any necessary license, registration, certification, or permit from the 
Colorado Department of Agriculture pursuant to the Pesticide Act, sections 35-9-101 et seq., 
C.R.S., and/or the Pesticide Applicators’ Act, sections 35-10-101 et seq., C.R.S. 
1. A Marijuana Research and Development Facility engaged in research activities involving 
Pesticide shall at all times comply with the Pesticide Act, sections 35-9-101 et seq., 
C.R.S., Pesticide Applicators’ Act, sections 35-10-101 et seq., C.R.S., and all rules 
promulgated pursuant thereto. 
C. Research Involving Human Subjects. A Marijuana Research and Development Facility shall not 
conduct any research involving human subjects unless all aspects of its proposed Research 
Project have been reviewed and approved by an Institutional Review Board that is registered and 
in good standing with Office for Human Research Protections, U.S. Department of Health and 
Human Services. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 386 
1. A Marijuana Research and Development Facility shall include proof of approval and 
ongoing oversight and review by an Institutional Review Board as part of its Research 
Project proposal. A Research Project may be approved conditioned upon subsequent 
Institutional Review Board approval. A Licensee shall not engage in any Research 
Project involving human subjects until it receives approval by the Institutional Review 
Board and its Research Project is approved. A Marijuana Research and Development 
Facility conducting research involving human subjects shall also comply with any ongoing 
monitoring required by the Institutional Review Board. 
2. A Marijuana Research and Development Facility conducting research involving human 
subjects shall at all times comply with the U.S. Department of Health and Human 
Services’ requirements for protection of human research subjects, including additional 
safeguards necessary for vulnerable populations, such as children, prisoners, pregnant 
women, mentally disabled persons, or economically or educationally disadvantaged 
persons, 45 C.F.R. part 46, and all other relevant federal and/or state laws and 
regulations regarding research on human subjects, as well as all prevailing ethical 
standards and requirements for research involving human subjects. 
3. A Marijuana Research and Development Facility conducting research involving human 
subjects shall obtain informed consent from any individual participating in such research 
prior to the individual’s participation in the research. A Marijuana Research and 
Development Facility shall comply with U.S. Food and Drug Administration requirements 
for informed consent and additional safeguards for children in clinical investigations, 21 
C.F.R. part 50, as part of approval and ongoing oversight and review by an Institutional 
Review Board. 
D. Research Involving Animal Subjects. A Marijuana Research and Development Facility shall not 
conduct any research involving animal subjects as defined in the Animal Welfare Act, 7 U.S.C. § 
2132(g) unless the Marijuana Research and Development Facility is registered with the U.S. 
Department of Agricultural pursuant to the Animal Welfare Act, 7 U.S.C. §§ 2131 et seq. 
1. A Marijuana Research and Development Facility shall include proof of its current 
registration with the U.S. Department of Agriculture as part of its Research Project 
proposal. Failure to be registered with the U.S. Department of Agriculture shall be 
grounds for denial of Research Project proposal involving animal subjects. 
2. A Marijuana Research and Development Facility shall at all times treat animal subjects as 
defined in the Animal Welfare Act, 7 U.S.C. § 2132(g) involved in research humanely and 
consistent with all relevant federal and/or state laws and regulations, as well as all 
prevailing ethical standards and requirements for research on such animals. 
E. Research Involving Testing of Marijuana. A Marijuana Research and Development Facility may 
only engage in research regarding the testing of Medical Marijuana if the following criteria are 
met: 
1. Testing Qualifications. A Marijuana Research and Development Facility must meet at 
least one of the following standards: 
a. The Marijuana Research and Development Facility also holds a Medical 
Marijuana Testing Facility license and has been certified pursuant to Rule 5-415; 
b. The Marijuana Research and Development Facility is accredited to the 
International Organization for Standardization/International Electrotechnical 
Commission 17025:2005 Standard, or any subsequent superseding ISO 17025 
standard; or 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 387 
c. The Marijuana Research and Development Facility is part of an institution of 
higher education whose protocols have been approved by the Colorado 
Department of Public Health and Environment. 
2. A Marijuana Research and Development Facility proposing to engage in research 
regarding the testing of Medical Marijuana shall include in its Research Project proposal 
documentation establishing its testing qualification pursuant to Psubparagraph (E)(1) of 
this Rule. See Rule 5-715 – Marijuana Research and Development Facilities: Project 
Approval. 
F. Transfers of Marijuana Used in Research. A Marijuana Research and Development Facility shall 
not Transfer to any Person any Medical Marijuana unless such Transfer is authorized under Rule 
5-710. Otherwise, a Marijuana Research and Development Facility shall at the conclusion of its 
research destroy all remaining Medical Marijuana subject to the Marijuana Research and 
Development Facility’s approved Research Project. Unless otherwise provided, a Research 
Project will be deemed concluded on its defined end date as provided in the Marijuana Research 
and Development Facility’s Research Project proposal that was submitted to and approved by the 
Division. The Marijuana Research and Development Facility shall ensure destruction of such 
remaining Medical Marijuana is destroyed in conformance with Rule 3-230. 
G. Periodic Reporting. A Marijuana Research and Development Facility shall submit to the Division a 
report regarding the status of approved Research Projects every six months following the 
Division’s approval of its Research Project. 
1. The periodic reports shall address the Marijuana Research and Development Facility’s 
compliance and progress with its approved Research Project. 
2. The periodic reports shall include any protocol changes or reported protocol deviations, 
as well as enrollment numbers and adverse events for studies involving human subjects. 
3. If the Marijuana Research and Development Facility is conducting its Research Project in 
whole or in part with a Public Institution or Public Money, the Division shall submit the 
Marijuana Research and Development Facility’s periodic reports to the Scientific Advisory 
Council for review. 
4. If an adverse event occurs, the Marijuana Research and Development Facility shall 
immediately notify the Division of the adverse event on the form prepared by the Division. 
H. Suspension or Revocation of Project Approval. Research Project approval is subject to revocation 
or suspension if the Marijuana Research and Development Facility’s research has materially 
diverged from the Marijuana Research and Development Facility’s approved Research Project, 
violates the Marijuana Code or the rules promulgated thereto, or presents a risk to public health 
and safety. See 8-200 Series Rules – Discipline. 
I. Reporting of Research Results. A Marijuana Research and Development Facility shall supply the 
Division with copies of all final reports, findings, or documentation regarding the outcomes of 
approved Research Projects. 
J. Independent Research Audit. The State Licensing Authority in its discretion may at any time 
require that a Marijuana Research and Development Facility undergo an audit of its research 
activities. 
1. Circumstances Justifying Independent Research Audit. The following is a non-exhaustive 
list of examples that may justify an independent research audit: 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 388 
a. The Division has reasonable grounds to believe that the Marijuana Research and 
Development Facility is in violation of one or more of the requirements set forth in 
these rules or other applicable statutes or regulations; 
b. The Division has reasonable grounds to believe that the Marijuana Research and 
Development Facility’s research activities present a danger to the public health 
and/or safety; or 
c. The Division has reasonable grounds to believe that the Marijuana Research and 
Development Facility has been or is engaged in research activities that have not 
received prior Division approval. 
2. Selection of An Independent Consultant. The Division and the Marijuana Research and 
Development Facility may attempt to mutually agree upon the selection of an 
independent consultant to perform a research audit. However, the Division always retains 
the authority to select the independent consultant regardless of whether mutual 
agreement can be reached. 
3. Costs. The Marijuana Research and Development Facility subject to an independent 
research audit will be responsible for all costs associated with the independent research 
audit, including but not limited to the auditor’s fees. 
4. Compliance Required. A Marijuana Research and Development Facility must pay for and 
timely cooperate with the State Licensing Authority’s requirement that it undergo an 
independent research audit in conformance with this Rule. 
K. Repealed. 
Basis and Purpose – 5-725 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(s), 44-10-401(1)(a)(VII), and 44-10-507, C.R.S. The 
purpose of this rule is to permit laboratory testing of Medical Marijuana, Medical Marijuana Concentrate, 
and Medical Marijuana Products used by Marijuana Research and Development Facilities. The State 
Licensing Authority intends this rule to help maintain the integrity of Colorado's Marijuana Research and 
Development Facilities. This Rule 5-725 was previously Rule M 1907, 1 CCR 212-1. 
5-725 – Marijuana Research and Development Facility: Testing 
A. Test Batches on Demand. Upon request of the Division, a Marijuana Research and Development 
Facility shall submit a sufficient quantity of Medical Marijuana to a Medical Marijuana Testing 
Facility for testing. The Division will notify the Marijuana Research and Development Facility of 
the results of the analysis. See Rule 3-805 – Medical Marijuana Business: Inventory Tracking 
System; Rule 3-905 – Business Records Required. 
B. Test Batches Provided for Testing. A Marijuana Research and Development Facility may provide 
Test Batches of its Medical Marijuana to a Medical Marijuana Testing Facility for testing 
purposes. The Marijuana Research and Development Facility shall maintain the testing results as 
part of its business books and records. See Rule 3-905 – Business Records Required. 
Basis and Purpose – 5-730 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(s), 44-10-401(1)(a)(VII), and 44-10-507, C.R.S. The 
purpose of this rule is to establish a Marijuana Research and Development Facility may only possess an 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 389 
amount of Medical Marijuana, Medical Marijuana Concentrate, or Medical Marijuana Product Medical 
Marijuana approved in conjunction with the Licensee’s approved Research Projects. The purpose of this 
rule is also to establish additional Inventory Tracking and separation requirements for Medical Marijuana 
cultivated for Transfer by a Marijuana Research and Development Cultivation. This Rule 5-730 was 
previously Rule M 1908, 1 CCR 212-1. 
5-730 – Marijuana Research and Development Facility: Production Management and Possession 
Limits 
A. Marijuana Authorized for Transfer. A Marijuana Research and Development Facility that is 
authorized to cultivate Medical Marijuana for Transfer to other Marijuana Research and 
Development Facilities may not have more than 500 Medical Marijuana plants and 20 pounds of 
Medical Marijuana in its Limited Access Area at any given time, unless expressly approved by the 
Division as part of an approved Research Project. 
1. A Marijuana Research and Development Facility shall indicate in the Inventory Tracking 
System whether Medical Marijuana is going to be used by the Licensee in an approved 
Research Project or Transferred to another Marijuana Research and Development 
Facility. A Marijuana Research and Development Facility may cultivate Medical Marijuana 
prior to approval of a Research Project, except the Marijuana Research and 
Development Facility may only designate such Medical Marijuana as Medical Marijuana 
to be Transferred to other Marijuana Research and Development Facilities unless the 
Marijuana Research and Development Facility has an approved Research Project. Upon 
approval of a Research Project, a Marijuana Research and Development Facility shall 
indicate in the Inventory Tracking System whether any such Medical Marijuana 
authorized for Transfer will be subject to the Marijuana Research and Development 
Facility’s research pursuant to the approved Research Project. 
B. Marijuana for Research. A Marijuana Research and Development Facility shall only possess for 
research the amount of Medical Marijuana approved by the Division pursuant to each of the 
Licensee’s approved Research Projects. 
C. Separation of Marijuana Used in Research. A Marijuana Research and Development Facility shall 
physically separate all Medical Marijuana used in the Licensee’s own approved Research 
Project(s) from Medical Marijuana to be Transferred to other Marijuana Research and 
Development Facilities for approved Research Projects. 
Part 6 – Retail Marijuana Business License Types 
6-100 Series – Retail Marijuana Stores and Accelerator Stores 
Basis and Purpose – 6-101 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(k), 
44-10-203(2)(aa), 44-10-401(2)(b)(I), 44-10-401(2)(b)(XI), 44-10-601, and 44-10-611, C.R.S. The 
purpose of this rule is to clarify the use of the terms Retail Marijuana Store Licensee and Accelerator 
Store Licensee throughout this 6-100 Series Rules and all other rules impacting Retail Marijuana Store 
and Accelerator Store compliance. 
6-101 – Retail Marijuana Store and Accelerator Store Applicability 
The definition of Retail Marijuana Store includes Accelerator Store. The Rules apply to both Retail 
Marijuana Stores and Accelerator Stores, except where the term Accelerator Store is used to refer 
exclusively to an Accelerator Store.  

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 390 
Basis and Purpose – 6-105 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(k), 
44-10-203(2)(aa), 44-10-203(2)(dd), 44-10-313(14), 44-10-401(2)(b)(I), 44-10-401(2)(b)(XI), 44-10-601, 
and 44-10-605, and 44-10-611, C.R.S. The purpose of this rule is to the license privileges of a Retail 
Marijuana Store Licensee. This Rule 6-105 was previously Rule R 401, 1 CCR 212-2, and includes 
provisions previously reflected in Rule 6-1105, 1 CCR 212-3. 
6-105 – Retail Marijuana Store: License Privileges 
A. Licensed Premises.  
1. To the extent authorized by Rule 3-215,  – Regulated Marijuana Business– Shared 
Licensed Premises and Operational Separation, a Retail Marijuana Store may share, and 
operate at, the same Licensed Premises with a commonly-owned Medical Marijuana 
Store. However, a separate License is required for each specific business or business 
entity, regardless of geographical location. 
2. Shared Licensed Premises. An Accelerator Store may operate on the same Licensed 
Premises as a Retail Marijuana Store that is an Accelerator-Endorsed Licensee pursuant 
to the 3-1100 Series Rules. 
3. Separate Licensed Premises. An Accelerator Store may operate on a separate premises 
in the possession of a Retail Marijuana Store that is an Accelerator-Endorsed Licensee 
pursuant to the 3-1100 Series Rules. 
4. To the extent authorized by Rule 3-215, an Accelerator Store may share, and operate at, 
the same Licensed Premises as an Accelerator-Endorsed Licensee’s Retail Marijuana 
Store that shares a Licensed Premises with a Medical Marijuana Store. 
B. Authorized Sources of Retail Marijuana. A Retail Marijuana Store may only Transfer Retail 
Marijuana that was obtained from another Retail Marijuana Business. 
B.5. Authorized Transfers to Retail Marijuana Businesses. A Retail Marijuana Store may Transfer 
Retail Marijuana to a customer or other Retail Marijuana Businesses. 
C. Test Batches Provided for Testing. A Retail Marijuana Store may provide Test Batches of its 
products for testing and research purposes to a Retail Marijuana Testing Facility. The Retail 
Marijuana Store shall maintain the testing results as part of its business books and records. See 
Rule 3-905 – Business Records Required. 
D. Authorized On-Premises Storage. A Retail Marijuana Store is authorized to store inventory on the 
Licensed Premises. All inventory stored on the Licensed Premises must be secured in a Limited 
Access Area or Restricted Access Area, and tracked consistently with the inventory tracking 
rules. 
E. Authorized Marijuana Transport. A Retail Marijuana Store is authorized to utilize a licensed Retail 
Marijuana Transporter for transportation of its Retail Marijuana so long as the place where 
transportation orders are taken and delivered is a licensed Retail Marijuana Business. Nothing in 
this Rule prevents a Retail Marijuana Store from transporting its own Retail Marijuana. 
F. Performance-Based Incentives. A Retail Marijuana Store may compensate its employees using 
performance-based incentives, including sales-based performance-based incentives. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 391 
G. Authorized Transfers of Hemp Products. This rule is effective July 1, 2020. A Retail Marijuana 
Store may Transfer Hemp Product to a consumer only after it has confirmed: 
1. That the Hemp Product has passed all required testing pursuant to the 4-200 Series 
Rules at a Retail Marijuana Testing Facility; and 
2. That the Person Transferring the Hemp Product to the Retail Marijuana Store is 
registered with the Colorado Department of Public Health and Environment as a Hemp 
Product Manufacturer pursuant to section 25-5-427, C.R.S.. 
G.5. Authorized Food Transfers. A Retail Marijuana Store may sell food that is not infused with 
marijuana if the annual gross revenues from the sale of food does not exceed twenty (20) percent 
of the Retail Marijuana Store’s total annual gross revenues. 
H. Retail Marijuana Store Delivery Permit. 
1. Repealed.Prior to January 2, 2021, all Retail Marijuana Stores are prohibited from 
delivering Regulated Marijuana to consumers. 
2. After January 2, 2021, aA Retail Marijuana Store with a valid delivery permit may accept 
delivery orders deliver Retail Marijuana to consumers pursuant to Rule 3-615. 
3. A Retail Marijuana Store that does not possess a valid delivery permit cannot deliver 
Retail Marijuana. 
I. Automated Dispensing Machines:. A Retail Marijuana Store may use an automated machine in 
the Restricted Access Area of its Licensed Premises to dispense Regulated Marijuana to 
consumers without interaction with an Owner Licensee or Employee Licensee if the automated 
machine is reasonably monitored and complies with all requirements of these rules including but 
not limited to: 
1. Health and safety standards, 
2. Testing, 
3. Packaging and labeling requirements, 
4. Inventory tracking, 
5. Identification requirements, and 
6. Transfer limits to consumers. 
J. Walk-up Window or Drive-up Window. A Retail Marijuana Store may serve customers through a 
walk-up window or drive-up window pursuant to the requirements of this Rule. 
1. Repealed. 
2. The area immediately outside the walk-up window or drive-up window must be under the 
Licensee’s possession and control and cannot include any public property such as public 
streets, public sidewalks, or public parking lots. 
3. Order and Identification Requirements. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 392 
a. Prior to accepting an order or Transferring Retail Marijuana to a customer, the 
Employee Licensee or Owner Licensee must physically view and inspect the 
consumer’s identification and ensure that the consumer is 21 years of age or 
older. 
b. The Retail Marijuana Store may accept telephone or internet orders or may 
accept orders from the customer at the walk-up window or drive-up window. 
c. All orders received through a walk-up window or a drive-up window must be 
placed by the customer from a menu. The Retail Marijuana Store may not display 
Retail Marijuana at the walk-up or drive-up window. 
4. Payment Requirements. Cash, credit, debit, cashless ATM, or other payment methods, 
including online payments are permitted for Retail Marijuana at the walk-up window or 
drive-up window. 
5. Video Surveillance Requirements. For every Transfer of Regulated Marijuana through 
either a walk-up window or drive-up window, the Retail Marijuana Store’s video 
surveillance must enable the recording of the consumer’s identity (and consumer’s 
vehicle in the event of drive-up window), and must enable the recording of the Licensee 
verifying the consumer’s identification and completion of the transaction through the 
Transfer of Regulated Marijuana. 
6. Packaging and Labeling Requirements. A Retail Marijuana Store utilizing a walk-up 
window or drive-up window must ensure that all Retail Marijuana is packaged and labeled 
in accordance with Rule 3-1010 and Rule 3-1015 prior to Transfer to the consumer. 
7. Local Restrictions. Transfers of Regulated Marijuana using a walk-up window or drive-up 
window are subject to requirements and restrictions imposed by the relevant Local 
Jurisdiction. 
K. Sales over the Internet. A Retail Marijuana Store may accept orders and payment for Retail 
Marijuana over the internet. 
1. Online Order Requirements. 
a. Online orders must include the customer’s name and date of birth. 
b. Prior to accepting the order, the store must provide and the customer must 
acknowledge receipt of: 
i. A digital copy of the pregnancy warning required in Rule 6-115; and 
ii. If accepting an order for Retail Marijuana Concentrate, the Retail 
Marijuana Store must also provide the educational resource required in 
Rule 6-110(C.5). 
c. Licensees must maintain Standard Operating Procedures documenting their 
compliance with the requirements of this subparagraph (K). 
2. Transfer of Retail Marijuana to the Customer. 
a. A customer must be physically present on the Licensed Premises to take 
possession of Retail Marijuana. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 393 
b. The Retail Marijuana Store must verify the customer’s physical identification 
matches the name and date of birth the customer provided at the time of the 
order, and verify that the customer is twenty-one years of age or older, in 
accordance with these Rules. 
3. Delivery. A Retail Marijuana Store that holds a valid delivery permit may make sales of 
Retail Marijuana over the internet in accordance with Rule 3-615. 
4. Approved Sources of Payment. A Retail Marijuana sStore may accept payment using any 
legal method of payment, gift card pre-payments, or pre-payment accounts established 
with a Retail Marijuana Store except that any payment with an Electronic Benefits 
Transfer Services Card is not permitted. 
a. A Local Licensing Authority or Local Jurisdiction may further restrict legal 
methods of payment not expressly permitted by section 44-10-203(2)(dd)(XV), 
C.R.S. 
Basis and Purpose – 6-110 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(2)(g), 
44-10-203(2)(h), 44-10-203(4)(b), 44-10-203(1)(k), 44-10-203(2)(aa) 44-10-401(2)(b)(I), 44-10-
401(2)(b)(XI), 44-10-701(1)(a), 44-10-701(3)(d) and (f), and 44-10-601 and 44-10-611, C.R.S. Authority 
also exists in the Colorado Constitution at Article XVIII, Subsections 16(3)(a), 16(5)(a)(V) and 
16(5)(a)(VIII). The purpose of this rule is to clarify those acts that are limited in some fashion, or 
prohibited, by a licensed Retail Marijuana Store. 
Regarding quantity limitations on sales, equivalencies for Retail Marijuana Concentrate and Retail 
Marijuana Product to Retail Marijuana flower have been included in this rule pursuant to the mandate of 
House Bill 14-1361. The establishment of equivalencies also provides information to stakeholders 
including Licensees, the general public, and law enforcement to aid in the enforcement of and compliance 
with the lawful personal possession limit of one ounce or less of marijuana. Setting these equivalencies 
provides Retail Marijuana Stores and their employees with necessary information to avoid being complicit 
in a patron acquiring more marijuana than is lawful to possess under the Colorado Constitution pursuant 
to Article XVIII, Subsection 16(3)(a). 
This Rule 6-110 was previously Rule R 402, 1 CCR 212-2, and includes provisions previously reflected in 
Rule 6-1110, 1 CCR 212-3. 
6-110 – Retail Marijuana Sales: General Limitations or Prohibited Acts 
A. Sales to Persons Under 21 Years. Licensees are prohibited from Transferring, giving, or 
distributing Retail Marijuana to persons under 21 years of age. Licensees are prohibited from 
permitting a person under the age of 21 years of age from entering the Restricted Access Area. 
B. Age Verification. Licensees must verify on two separate occasions that a Person is 21 years of 
age or older. First, prior to permitting a Person to enter the Restricted Access Area, a Licensee 
must verify that the Person has a valid government-issued photo identification showing that the 
Person is 21 years of age or older. Second, prior to initiating the Transfer of Retail Marijuana, a 
Licensee must verify that the purchaser has a valid government-issued photo identification 
showing that the purchaser is 21 years of age or older. 
C. Quantity Limitations On Sales. 
1. A Retail Marijuana Store and its employees are prohibited from Transferring more than 
one ounce of Retail Marijuana flower or its equivalent in Retail Marijuana Concentrate or 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 394 
Retail Marijuana Product to a consumer in a single transaction. A Retail Marijuana Store 
may also Transfer up to six (6) seeds in addition to the one ounce of Retail Marijuana 
flower or its equivalent in Retail Marijuana Concentrate or Retail Marijuana Product to a 
consumer in a single transaction. A single transaction includes multiple Transfers to the 
same consumer during the same business day where the Retail Marijuana Store 
employee knows or reasonably should know that such Transfer would result in that 
consumer possessing more than one ounce of marijuana. In determining the imposition 
of any penalty for violation of this Rule 6-110(C), the State Licensing Authority will 
consider any mitigating and aggravating factors set forth in Rule 8-235(C). 
2. Equivalency. Non-edible, non-psychoactive Retail Marijuana Products including 
ointments, lotions, balms, and other non-transdermal topical products are exempt from 
the one-ounce quantity limit on Transfers. For all other Retail Marijuana Products or 
Retail Marijuana Concentrate, the following equivalency applies for the one-ounce 
quantity Transfer limit: 
a. One ounce of Retail Marijuana flower shall be equivalent to eight grams of Retail 
Marijuana Concentrate. 
b. One ounce of Retail Marijuana flower shall be equivalent to 80 ten-milligram 
servings of THC in Retail Marijuana Product. 
C.5. Educational Resource. When completing a sale of Retail Marijuana Concentrate, a Retail 
Marijuana Store shall physically attach to the consumer’s receipt of sale, product container, or 
exit packaging the tangible educational resource created by the State Licensing Authority 
regarding the use of Regulated Marijuana Concentrate. 
D. Licensees May Refuse Sales. Nothing in these rules prohibits a Licensee from refusing to 
Transfer Retail Marijuana to a consumer. 
E. Repealed. 
F. Delivery Outside Colorado Prohibited. A Retail Marijuana Store holding a valid delivery permit 
shall not deliver Retail Marijuana to an address that is outside the state of Colorado. 
G. Prohibited Items. A Retail Marijuana Store is prohibited from selling or giving away cigarettes or 
tobacco products, and alcohol beverages. 
H. Free Product Prohibited. A Retail Marijuana Store may not give away Retail Marijuana to a 
consumer for any reason. 
I. Nicotine or Alcohol Prohibited. A Retail Marijuana Store is prohibited from Transferring Retail 
Marijuana that contain nicotine or alcohol, if the sale of the alcohol would require a license 
pursuant to Articles 3, 4, or 5 of Title 44, C.R.S. 
J. Storage and Display Limitations. 
1. A Retail Marijuana Store shall not display Retail Marijuana outside of a designated 
Restricted Access Area or in a manner in which Retail Marijuana can be seen from 
outside the Licensed Premises. Storage of Retail Marijuana shall otherwise be 
maintained in Limited Access Areas or a designated Restricted Access Area. 
2. Any Retail Marijuana Concentrate displayed in a Retail Marijuana Store must include the 
potency of the concentrate on a sign next to the name of the product. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 395 
a. The font on the sign must be large enough for a consumer to reasonably see 
from the location where a consumer would usually view the concentrate. 
b. The potency displayed on the sign must be within plus or minus fifteen percent of 
the concentrate’s actual potency. 
K. Transfer of Expired Product Prohibited. A Retail Marijuana Store shall not Transfer any expired 
Edible Retail Marijuana Product, Vaporizer Delivery Device, Pressurized Metered Dose Inhaler, 
Audited Marijuana Product, or Alternative Use Product to a consumer. 
L. Transfer Restriction. 
1. SamplingR-and-D Units. A Retail Marijuana Store may not possess or Transfer 
SamplingR-and-D Units. 
2. Research Transfers Prohibited. A Retail Marijuana Store shall not Transfer any Retail 
Marijuana to a Pesticide Manufacturer, or a Marijuana Research and Development 
Facility. 
L.5. Standard Operating Procedures. A Retail Marijuana Store must establish written Standard 
Operating Procedures for the management and storage of Retail Marijuana inventory and the 
sale of Retail Marijuana to consumers. A written copy of the Standard Operating Procedures must 
be maintained on the Licensed Premises. 
1. A Retail Marijuana Store must provide adequate training to every Owner Licensee and 
Employee Licensee who performs a task or set of tasks that are referenced in the 
Standard Operating Procedures. Adequate training must include, but need not be limited 
to, providing a copy of the Standard Operating Procedures for that Licensed Premises 
detailing at least all of the topics required to be included in the Standard Operating 
Procedures. 
M. Edibles Prohibited that are Shaped like a Human, Animal, or Fruit. 
1. The sale of Edible Retail Marijuana Products in the following shapes is prohibited: 
a. The distinct shape of a human, animal, or fruit; or 
b. A shape that bears the likeness or contains characteristics of a realistic or 
fictional human, animal, or fruit, including artistic, caricature, or cartoon 
renderings. 
2. The prohibition on human, animal, and fruit shapes does not apply to the logo of a 
licensed Retail Marijuana Business. Nothing in this subparagraph (M)(2) alters or 
eliminates a Licensee’s obligation to comply with the requirements of the 3-1000 Series 
Rules – Labeling, Packaging, and Product Safety. 
3. Edible Retail Marijuana Products that are geometric shapes and simply fruit flavored are 
not considered fruit and are permissible; and 
4. Edible Retail Marijuana Products that are manufactured in the shape of a marijuana leaf 
are permissible. 
N. Adverse Health Event Reporting. A Retail Marijuana Store must report Adverse Health Events 
pursuant to Rule 3-920. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 396 
O. Corrective and Preventive Action. This paragraph O shall be effective January 1, 2021. A Retail 
Marijuana Store shall establish and maintain written procedures for implementing Corrective 
Action and Preventive Action. The written procedures shall include the requirements listed below 
as determined by the Licensee. All activities required under this Rule, and their results, shall be 
documented and kept as business records. See Rule 3-905. The written procedures shall include 
requirements, as appropriate, for: 
1. What constitutes a Nonconformance in the Licensee’s business operation; 
2. Analyzing processes, work operations, reports, records, service records, complaints, 
returned product, and/or other sources of data to identify existing and potential root 
causes of Nonconformances or other quality problems; 
3. Investigating the root cause of Nonconformances relating to product, processes, and the 
quality system; 
4. Identifying the action(s) needed to correct and prevent recurrence of Nonconformance 
and other quality problems; 
5. Verifying the Corrective Action or Preventive Action to ensure that such action is effective 
and does not adversely affect finished products; 
6. Implementing and recording changes in methods and procedures needed to correct and 
prevent identified quality problems; 
7. Ensuring the information related to quality problems or Nonconformances is disseminated 
to those directly responsible for assuring the quality of products or the prevention of such 
problems; and 
8. Submitting relevant information on identified quality problems and Corrective Action and 
Preventive Action documentation, and confirming the result of the evaluation, for 
management review. 
P. Repealed. 
Basis and Purpose – 6-115 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(2)(z), 44-10-203(2)(aa), and 44-10-202(3)(h), 44-10-401(2)(b)(I), 44-10-
401(2)(b)(XI), 44-10-601, and 44-10-611, C.R.S. Authority also exists in the Colorado Constitution at 
Article XVIII, Subsections 16(5)(a)(V) and 16(5)(a)(VIII). The purpose of this rule is to establish that a 
Retail Marijuana Store must control and safeguard access to certain areas where Retail Marijuana and 
Retail Marijuana Product will be sold to the general public and prevent the diversion of Retail Marijuana 
and Retail Marijuana Product to people under 21 years of age. This Rule 6-115 was previously  Rule R 
403, 1 CCR 212-2, and includes provisions previously reflected in Rule 6-1115, 1 CCR 212-3. 
6-115 – Point of Sale: Restricted Access Area 
A. Identification of Restricted Access Area. All areas where Retail Marijuana are sold, possessed for 
sale, displayed, or dispensed for sale shall be identified as a Restricted Access Area and shall be 
clearly identified by the posting of a sign which shall be not less than 12 inches wide and 12 
inches long, composed of letters not less than a half inch in height, which shall state, “Restricted 
Access Area – No One Under 21 Years of Age Allowed.” 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 397 
B. Consumers in Restricted Access Area. The Restricted Access Area must be supervised by a 
Licensee at all times when consumers are present to ensure that only persons who are 21 years 
of age or older are permitted to enter. When allowing a customer access to a Restricted Access 
Area, Owner Licensees and Employee Licensees shall make reasonable efforts to limit the 
number of consumers in relation to the number of Owners Licensees and Employee Licensees in 
the Restricted Access Area at any time. 
C. Display of Retail Marijuana. The display of Retail Marijuana for sale is allowed only in Restricted 
Access Areas. Any product displays that are readily accessible to the consumer must be 
supervised by the Owner Licensee or Employee Licensees at all times when consumers are 
present. 
D. Pregnancy Warning. Retail Marijuana Stores must post, at all times and in a prominent place at 
every point-of-sale inside the Restricted Access Area, a warning that is at minimum three inches 
high and six inches wide that reads: 
WARNING: Using marijuana, in any form, while you are pregnant or breastfeeding 
passes THC to your baby and may be harmful to your baby. There is no known safe 
amount of marijuana use during pregnancy or breastfeeding. 
6-200 Series – Retail Marijuana Cultivation Facilities and Accelerator Cultivators 
Basis and Purpose – 6-201 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(k), 
44-10-203(2)(aa), 44-10-401(2)(b)(II), 44-10-401(2)(b)(VII), 44-10-602, and 44-10-607, C.R.S. The 
purpose of this rule is to clarify the use of the terms Retail Marijuana Cultivation Facility Licensee and 
Accelerator Cultivator Licensee throughout this 6-200 Series Rules and all other rules impacting Retail 
Marijuana Cultivation Facility and Accelerator Cultivator compliance. 
6-201 – Retail Marijuana Cultivation Facility and Accelerator Cultivator Applicability 
The definition of Retail Marijuana Cultivation Facility includes Accelerator Cultivator. The Rules apply to 
both Retail Marijuana Cultivation Facilities and Accelerator Cultivators, except where the term Accelerator 
Cultivator is used to refer exclusively to an Accelerator Cultivator.  
Basis and Purpose – 6-205 
The statutory authority for this rule includes but is not limited to sections 44-10-202(1)(c), 44-10-203(1)(c), 
44-10-203(1)(k), 44-10-203(2)(h), 44-10-203(2)(j), 44-10-203(2)(r), 44-10-203(2)(aa), 44-10-203(3)(c), 44-
10-313(14), 44-10-401(2)(b)(II), 44-10-401(2)(b)(VII), and 44-10-602, and 44-10-607 C.R.S. The purpose 
of this rule is to establish the license privileges granted by the State Licensing Authority to a Retail 
Marijuana Cultivation Facility. This Rule 6-205 was previously Rule R 501, 1 CCR 212-2, and includes 
provisions previously reflected in Rule 6-705, 1 CCR-3. 
6-205 – Retail Marijuana Cultivation Facility: License Privileges 
A. Licensed Premises. To the extent authorized by Rule 3-215 – Regulated Marijuana Businesses: 
Shared Licensed Premises and Operational Separation, a Retail Marijuana Cultivation Facility 
may share, and operate at, the same Licensed Premises with a commonly owned Medical 
Marijuana Cultivation Facility. However, a separate license is required for each specific business 
or business entity, regardless of geographical location. In addition, a Retail Marijuana Cultivation 
Facility may share, and operate at, the same Licensed Premises as a Marijuana Research and 
Development Facility so long as: 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 398 
1. Each business or business entity holds a separate license; 
2. The Marijuana Research and Development Facility obtains an R&D Co-Location Permit; 
3. Both the Marijuana Research and Development Facility and the Retail Marijuana 
Cultivation Facility comply with all terms and conditions of the R&D Co-Location Permit; 
and 
4. Both the Marijuana Research and Development Facility and the Retail Marijuana 
Cultivation Facility comply with all applicable rules. See 5-700 Series Rules. 
A.5. Licensed Premises – Accelerator Cultivators. 
1. Shared Licensed Premises. An Accelerator Cultivator may operate on the same Licensed 
Premises as a Retail Marijuana Cultivation Facility that is an Accelerator-Endorsed 
Licensee pursuant to the 3-1100 Series Rules. 
2. Separate Licensed Premises. An Accelerator Cultivator may operate on a separate 
premises in the possession of a Retail Marijuana Cultivation Facility that is an 
Accelerator-Endorsed Licensee pursuant to the 3-1100 Series Rules. 
3. To the extent authorized by Rule 3-215, a Retail Marijuana Cultivation Facility may share, 
and operate at, the same Licensed Premises with a commonly owned Medical Marijuana 
Cultivation Facility. However, a separate license is required for each specific business or 
business entity, regardless of geographical location. A Regulated Marijuana Business 
that is operating at the same premises as a commonly owned Medical Marijuana 
Business may become an Accelerator-Endorsed Licensee. An Accelerator Cultivator may 
operate at the premises where the Accelerator-Endorsed Licensee operates along with 
the commonly owned Medical Marijuana Cultivation Facility. 
B. Cultivation of Retail Marijuana and Production of Pre-Rolled Marijuana and Infused Pre-Rolled 
Marijuana from Physical Separation-Based Retail Marijuana Concentrate Authorized. A Retail 
Marijuana Cultivation Facility may propagate, cultivate, harvest, prepare, cure, package, store, 
and label Retail Marijuana and Physical Separation-Based Retail Marijuana Concentrate. A Retail 
Marijuana Cultivation Facility may also produce Pre-Rolled Marijuana and Infused Pre-Rolled 
Marijuana from Physical Separation-Based Retail Marijuana Concentrate. 
C. Authorized Transfers. A Retail Marijuana Cultivation Facility may only Transfer Retail Marijuana 
and Physical Separation-Based Retail Marijuana Concentrate to another Retail Marijuana 
Business. A Retail Marijuana Cultivation Facility and an Accelerator Cultivator may also Transfer 
to a Medical Marijuana Cultivation Facility in compliance with Rules 6-230 and 6-730. 
1. A Retail Marijuana Cultivation Facility shall not Transfer Flowering plants. A Retail 
Marijuana Cultivation Facility may only Transfer Vegetative plants as authorized pursuant 
to Rule 3-605. 
2. A Retail Marijuana Cultivation Facility may Transfer SamplingR-and-D Units of Retail 
Marijuana or Retail Marijuana Concentrate to a designated Sampling Manageremployee 
in accordance with the restrictions set forth in section 44-10-602(6), C.R.S., and Rule 6-
225. 
3. A Retail Marijuana Cultivation Facility may Transfer Retail Marijuana or Retail Marijuana 
Concentrate to another Retail Marijuana Cultivation Facility prior to testing required by 
these rules only if such Transfer is in accordance with one of the two options below. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 399 
a. The Retail Marijuana Cultivation Facility may Transfer Retail Marijuana, Retail 
Marijuana Concentrate, Pre-Rolled Marijuana, or Infused Pre-Rolled Marijuana to 
another Retail Marijuana Cultivation Facility prior to testing if such Transfer is to 
perform a Microbial Control Step and only after all other steps outlined in the 
Retail Marijuana Cultivation Facility’s Standard Operating Procedures have been 
completed, including but not limited to drying, curing, and trimming; or 
b. The Retail Marijuana Cultivation Facility may Transfer Retail Marijuana or Retail 
Marijuana Concentrate to another Retail Marijuana Cultivation Facility prior to 
testing, drying, curing, trimming, or completion of any other steps in the Retail 
Marijuana Cultivation Facility’s Standard Operating Procedures, subject to the 
following additional requirements: 
i. The Retail Marijuana Cultivation Facility receiving the Transfer is 
identified as a centralized processing hub in the Inventory Tracking 
System and must have identical Controlling Beneficial Owner(s) with the 
originating Retail Marijuana Cultivation Facility; 
ii. An originating Retail Marijuana Cultivation Facility may only Transfer 
Retail Marijuana to one receiving Retail Marijuana Cultivation Facility that 
will be serving as a centralized processing hub; 
iii. The Retail Marijuana or Retail Marijuana Concentrate is weighed prior to 
leaving the originating Retail Marijuana Cultivation Facility and 
immediately upon receipt at the receiving Retail Marijuana Cultivation 
Facility and in accordance with Rule 3-605; 
iv. The Transfer, weighing and entry into the Inventory Tracking System are 
all completed within 24 hours from initiating the Transfer; 
v. The receiving Retail Marijuana Cultivation Facility is responsible for 
compliance with all testing requirements regardless of any testing 
performed prior to Transfer. If the receiving Retail Marijuana Cultivation 
Facility is pursuing a Reduced Testing Allowance, a Reduced Testing 
Allowance must be achieved separately for marijuana received from 
each originating Retail Marijuana Cultivation Facility. A Retail Marijuana 
Cultivation Facility that has achieved a Reduced Testing Allowance must 
maintain and produce complete testing records that can verify that 
facility’s compliance with testing and Reduced Testing Allowance 
requirements; and 
vi. The Standard Operating Procedures for the originating Retail Marijuana 
Cultivation Facility and receiving Retail Marijuana Cultivation Facility 
clearly reflect the steps taken by each facility to Transfer, transport, 
receive, process, and test HarvestProduction Batches. 
4. A Retail Marijuana Cultivation Facility may tTransfer Retail Marijuana to a Pesticide 
Manufacturer. 
5. A Retail Marijuana Cultivation Facility may Transfer Retail Marijuana to a Medical 
Marijuana Cultivation Facility in accordance with Rules 5-235 and 6-230. 
6. A Retail Marijuana Cultivation Facility may sell, Ttransfer, or ship Genetic Material in 
accordance with section 44-10-602(12)(b), C.R.S. 

CODE OF COLORADO REGULATIONS 1 CCR 212-3 
Marijuana Enforcement Division 
 400 
D. Authorized On-Premises Storage. A Retail Marijuana Cultivation Facility is authorized to store 
inventory on the Licensed Premises. All inventory stored on the Licensed Premises must be 
